Biogen Idec Inc. (NASDAQ: BIIB) reports Q2 EPS of $0.91, 6 cents better than the analyst estimate of ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE